First and foremost, Fast, a three-year-old one-click checkout firm, announced its closure after failing to obtain further financing to keep operations going. The statement didn’t come as a complete surprise, given that The Information had reported on symptoms of problems the week before. Those hints included the revelation that the startup had only generated $600,000 in revenue for the entire year of 2021 despite raising $120 million in venture capital earlier in the year (in a round led by Stripe) and rumors that the company was having difficulty raising additional funds and, as a result, might be looking for a buyer.
Your new firm may begin modestly, but it does not imply that you will make a small investment. New projects frequently cost tens of thousands of dollars: According to an Inc. Magazine survey of fast-growing enterprises, 42 percent of organizations debuted in 2018 with $5,000 or less in investment, and 21 percent required $5,000 to $25,000.
AmerisourceBergen, a leading pharmaceutical distributor, is putting $150 million into a corporate venture fund focusing on healthcare entrepreneurs.
AB Health Ventures, the wholesale giant’s new venture capital fund, will first look to invest in early to midstage health-related firms both in the United States and abroad. According to management, the fund will target investments in businesses focused on pharmacy and distribution innovation, clinical development and commercialization of pharmaceuticals, practice solutions for healthcare practitioners, and animal health.
Read more. ➝
Base10 Partners was founded in 2018 by managing partners Ajao and TJ Nahigian. The San Francisco-based firm invests in automation technology across industries such as food and retail using a data-driven strategy. Base10 created an automated software program to watch startups in real time using a set of predictive data points; the 64 investments it has made represent 0.4 percent of the more than 15,000 companies it tracks.